Explore
Study of intracellular signaling pathways in Chronic Myeloproliferative Neoplasms
Serena Martinelli
2017
0 Ungluers have
Faved this Work
Login to Fave
A gain-of-function mutation in Janus kinase 2 (JAK2V617F) is at the basis of the majority of chronic myeloproliferative neoplasms (MPN). Enhanced activation of other downstream pathways including the PI3K/mTOR pathway has been documented as well. In this study we evaluated the effects of JAK1/2 inhibitors, alone and in combination with mTOR, with a dual mTOR/PI3K inhibitor and with a pan PI3K inhibitor in in-vitro and in-vivo MPN models. Our findings of strong synergy between the JAK2 inhibitors and mTOR/PI3K inhibitor suggested that we might be able to administer these drugs at lower concentrations than when the drugs are used individually. This provides a framework for combination trials using compounds in patients with myeloproliferative neoplasms
This book is included in DOAB.
Why read this book? Have your say.
You must be logged in to comment.
Rights Information
Are you the author or publisher of this work? If so, you can claim it as yours by registering as an Unglue.it rights holder.Downloads
This work has been downloaded 35 times via unglue.it ebook links.
- 35 - pdf (CC BY) at OAPEN Library.
Keywords
- Biochemistry
- Biology, Life Sciences
- Mathematics & science
- medicine
- Molecular biology
- Nursing & ancillary services
- Pharmacy / dispensing
- Pre-clinical medicine: basic sciences
- thema EDItEUR::M Medicine and Nursing::MF Pre-clinical medicine: basic sciences
- thema EDItEUR::M Medicine and Nursing::MQ Nursing and ancillary services::MQP Pharmacy / dispensing
- thema EDItEUR::P Mathematics and Science::PS Biology, life sciences
- thema EDItEUR::P Mathematics and Science::PS Biology, life sciences::PSB Biochemistry
- thema EDItEUR::P Mathematics and Science::PS Biology, life sciences::PSD Molecular biology
Links
DOI: 10.36253/978-88-6453-565-4Editions